======= UBE2V2 ======= == Gene Information == * **Official Symbol**: UBE2V2 * **Official Name**: ubiquitin conjugating enzyme E2 V2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7336|7336]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15819|Q15819]] * **Interactions**: [[https://thebiogrid.org/search.php?search=UBE2V2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20UBE2V2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603001|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Has no ubiquitin ligase activity on its own. The UBE2V2/UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through 'Lys-63'. This type of poly-ubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage. {ECO:0000269|PubMed:10089880, ECO:0000269|PubMed:14562038, ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:9705497}. |UQ con| |error-free postreplication DNA repair| |UBC13-MMS2 complex| |DNA double-strand break processing| |protein K63-linked ubiquitination| |ubiquitin conjugating enzyme activity| |postreplication repair| |double-strand break repair via nonhomologous end joining| |non-recombinational repair| |regulation of DNA repair| |double-strand break repair| |regulation of response to DNA damage stimulus| |protein polyubiquitination| |regulation of DNA metabolic process| |DNA repair| |protein ubiquitination| |regulation of cellular response to stress| |DNA metabolic process| |protein modification by small protein conjugation| |cellular response to DNA damage stimulus| |protein modification by small protein conjugation or removal| |regulation of response to stress| |cellular response to stress| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|1.75| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|1.96| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|2.25| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|2.29| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.4| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18897 * **Expression level (log2 read counts)**: 6.08 {{:chemogenomics:nalm6 dist.png?nolink |}}